{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:42:24Z","timestamp":1792687344631,"version":"4.5.0"},"reference-count":159,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T00:00:00Z","timestamp":1715212800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Infectious diseases caused by trypanosomatids, including African trypanosomiasis (sleeping sickness), Chagas disease, and different forms of leishmaniasis, are Neglected Tropical Diseases affecting millions of people worldwide, mainly in vulnerable territories of tropical and subtropical areas. In general, current treatments against these diseases are old-fashioned, showing adverse effects and loss of efficacy due to misuse or overuse, thus leading to the emergence of resistance. For these reasons, searching for new antitrypanosomatid drugs has become an urgent necessity, and different metabolic pathways have been studied as potential drug targets against these parasites. Considering that trypanosomatids possess a unique redox pathway based on the trypanothione molecule absent in the mammalian host, the key enzymes involved in trypanothione metabolism, trypanothione reductase and trypanothione synthetase, have been studied in detail as druggable targets. In this review, we summarize some of the recent findings on the molecules inhibiting these two essential enzymes for Trypanosoma and Leishmania viability.<\/jats:p>","DOI":"10.3390\/molecules29102214","type":"journal-article","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T05:16:45Z","timestamp":1715231805000},"page":"2214","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Targeting Trypanothione Metabolism in Trypanosomatids"],"prefix":"10.3390","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1069-3940","authenticated-orcid":false,"given":"Mar\u00eda-Cristina","family":"Gonz\u00e1lez-Montero","sequence":"first","affiliation":[{"name":"Departamento de Ciencias Biom\u00e9dicas, Facultad de Veterinaria, Universidad de Le\u00f3n, Campus de Vegazana s\/n, 24071 Le\u00f3n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7191-6007","authenticated-orcid":false,"given":"Julia","family":"Andr\u00e9s-Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Departamento de Ciencias Biom\u00e9dicas, Facultad de Veterinaria, Universidad de Le\u00f3n, Campus de Vegazana s\/n, 24071 Le\u00f3n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5177-293X","authenticated-orcid":false,"given":"Nerea","family":"Garc\u00eda-Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Departamento de Ciencias Biom\u00e9dicas, Facultad de Veterinaria, Universidad de Le\u00f3n, Campus de Vegazana s\/n, 24071 Le\u00f3n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"P\u00e9rez-Pertejo","sequence":"additional","affiliation":[{"name":"Departamento de Ciencias Biom\u00e9dicas, Facultad de Veterinaria, Universidad de Le\u00f3n, Campus de Vegazana s\/n, 24071 Le\u00f3n, Spain"},{"name":"Instituto de Biomedicina (IBIOMED), Universidad de Le\u00f3n, Campus de Vegazana s\/n, 24071 Le\u00f3n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9148-2997","authenticated-orcid":false,"given":"Rosa M.","family":"Reguera","sequence":"additional","affiliation":[{"name":"Departamento de Ciencias Biom\u00e9dicas, Facultad de Veterinaria, Universidad de Le\u00f3n, Campus de Vegazana s\/n, 24071 Le\u00f3n, Spain"},{"name":"Instituto de Biomedicina (IBIOMED), Universidad de Le\u00f3n, Campus de Vegazana s\/n, 24071 Le\u00f3n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0418-6116","authenticated-orcid":false,"given":"Rafael","family":"Bala\u00f1a-Fouce","sequence":"additional","affiliation":[{"name":"Departamento de Ciencias Biom\u00e9dicas, Facultad de Veterinaria, Universidad de Le\u00f3n, Campus de Vegazana s\/n, 24071 Le\u00f3n, Spain"},{"name":"Instituto de Biomedicina (IBIOMED), Universidad de Le\u00f3n, Campus de Vegazana s\/n, 24071 Le\u00f3n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5617-9669","authenticated-orcid":false,"given":"Carlos","family":"Garc\u00eda-Estrada","sequence":"additional","affiliation":[{"name":"Departamento de Ciencias Biom\u00e9dicas, Facultad de Veterinaria, Universidad de Le\u00f3n, Campus de Vegazana s\/n, 24071 Le\u00f3n, Spain"},{"name":"Instituto de Biomedicina (IBIOMED), Universidad de Le\u00f3n, Campus de Vegazana s\/n, 24071 Le\u00f3n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,5,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40249-020-0630-9","article-title":"Neglected tropical diseases: An effective global response to local poverty-related disease priorities","volume":"9","author":"Engels","year":"2020","journal-title":"Infect. Dis. Poverty"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.pt.2018.03.002","article-title":"Trypanosomatids Are Much More than Just Trypanosomes: Clues from the Expanded Family Tree","volume":"34","author":"Butenko","year":"2018","journal-title":"Trends Parasitol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"taac031","DOI":"10.1093\/jtm\/taac031","article-title":"Global burden and trends of neglected tropical diseases from 1990 to 2019","volume":"29","author":"Lin","year":"2022","journal-title":"J. Travel Med."},{"key":"ref_4","unstructured":"(2024, February 28). WHO. Available online: https:\/\/www.who.int\/health-topics\/neglected-tropical-diseases#tab=tab_1."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/bmb\/ldp046","article-title":"Neglected tropical diseases","volume":"93","author":"Feasey","year":"2010","journal-title":"Br. Med. Bull."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/trstmh\/traa192","article-title":"The impact of climate change on neglected tropical diseases: A systematic review","volume":"115","author":"Tidman","year":"2021","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.freeradbiomed.2008.05.028","article-title":"Insights into the redox biology of Trypanosoma cruzi: Trypanothione metabolism and oxidant detoxification","volume":"45","author":"Cibils","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e210401","DOI":"10.1590\/0074-02760210401","article-title":"Antioxidant defence system as a rational target for Chagas disease and Leishmaniasis chemotherapy","volume":"117","author":"Santi","year":"2022","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.actatropica.2018.04.008","article-title":"What makes an effective Chagas disease vector? Factors underlying Trypanosoma cruzi-triatomine interactions","volume":"183","author":"Lowenberger","year":"2018","journal-title":"Acta Trop."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.4269\/ajtmh.2012.12-0354","article-title":"Acute Chagas disease in a returning traveler","volume":"87","author":"Carter","year":"2012","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01787-7","article-title":"Chagas disease","volume":"403","author":"Vermeij","year":"2024","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jacc.2013.05.046","article-title":"Council on Chagas Disease of the Interamerican Society of Cardiology. Chagas disease: An overview of clinical and epidemiological aspects","volume":"62","author":"Nunes","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"100507","DOI":"10.1016\/j.cpcardiol.2019.100507","article-title":"Chagas Disease: Chronic Chagas Cardiomyopathy","volume":"46","author":"Stewart","year":"2021","journal-title":"Curr. Probl. Cardiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.idc.2012.03.002","article-title":"Tripanosomiasis americana (enfermedad de Chagas)","volume":"26","author":"Rassi","year":"2012","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(17)31612-4","article-title":"Chagas disease","volume":"391","author":"Molina","year":"2018","journal-title":"Lancet"},{"key":"ref_16","first-page":"1262","article-title":"Chagas Disease: Epidemiology and Barriers to Treatment","volume":"133","author":"Mills","year":"2020","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_17","first-page":"257","article-title":"Epidemiology of human African trypanosomiasis","volume":"6","author":"Franco","year":"2014","journal-title":"Clin. Epidemiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.idc.2018.10.003","article-title":"Human African Trypanosomiasis: Progress and Stagnation","volume":"33","author":"Bottieau","year":"2019","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s40475-023-00304-w","article-title":"Human African Trypanosomiasis (Sleeping Sickness)-Epidemiology, Clinical Manifestations, Diagnosis, Treatment, and Prevention","volume":"10","author":"Bongomin","year":"2023","journal-title":"Curr. Trop. Med. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/jme\/tjab225","article-title":"Review of the Situation of Human African Trypanosomiasis in the Republic of Congo From the 1950s to 2020","volume":"59","author":"Bemba","year":"2022","journal-title":"J. Med. Entomol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Jamabo, M., Mahlalela, M., Edkins, A.L., and Boshoff, A. (2023). Tackling sleeping sickness: Current and promising therapeutics and treatment strategies. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241512529"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev-pathmechdis-031621-025153","article-title":"The Pathogenesis of African Trypanosomiasis","volume":"18","author":"Pays","year":"2023","journal-title":"Annu. Rev. Pathol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/B978-0-444-53490-3.00011-X","article-title":"Human African trypanosomiasis","volume":"Volume 114","author":"Tanowitz","year":"2013","journal-title":"Handbook of Clinical Neurology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/S0140-6736(17)31510-6","article-title":"Human African trypanosomiasis","volume":"390","author":"Cecchi","year":"2017","journal-title":"Lancet"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1007\/s00415-019-09425-7","article-title":"Update on human African trypanosomiasis (sleeping sickness)","volume":"266","author":"Kennedy","year":"2019","journal-title":"J. Neurol."},{"key":"ref_26","first-page":"117","article-title":"Sleeping sickness","volume":"Volume 1","author":"Misra","year":"2020","journal-title":"Molecular Advancements in Tropical Diseases Drug Discovery"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Becvar, T., Vojtkova, B., Siriyasatien, P., Votipka, J., Modry, D., Jahn, P., Bates, P., Carpintero, S., Volf, P., and Sadlova, J. (2021). Experimental transmission of Leishmania (Mundinia) parasites by biting midges (Diptera: Ceratopogonidae). PLoS Pathog., 17.","DOI":"10.1371\/journal.ppat.1009654"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Cec\u00edlio, P., Cordeiro-da-Silva, A., and Oliveira, F. (2022). Sand flies: Basic information on the vectors of leishmaniasis and their interactions with Leishmania parasites. Commun. Biol., 5.","DOI":"10.1038\/s42003-022-03240-z"},{"key":"ref_29","first-page":"191","article-title":"Phlebotomine and sand flies and moth flies (Psychodidae)","volume":"Volume 1","author":"Mullen","year":"2019","journal-title":"Medical and Veterinary Entomology"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Sunyoto, T., Potet, J., and Boelaert, M. (2017). Visceral leishmaniasis in Somalia: A review of epidemiology and access to care. PLoS Negl. Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0005231"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s00436-021-07139-2","article-title":"Leishmaniasis: Where are we and where are we heading?","volume":"120","author":"Sasidharan","year":"2021","journal-title":"Parasitol. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s40257-022-00726-8","article-title":"Cutaneous Leishmaniasis: A 2022 Updated Narrative Review into Diagnosis and Management Developments","volume":"23","author":"Schallig","year":"2022","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_33","first-page":"3093","article-title":"Clinical manifestations of leishmaniasis: A Review","volume":"3","author":"Sachdeva","year":"2016","journal-title":"Int. J. Adv. Res. Sci. Eng. Technol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s40475-021-00232-7","article-title":"A Review of Leishmaniasis: Current Knowledge and Future Directions","volume":"8","author":"Mann","year":"2021","journal-title":"Curr. Trop. Med. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13071-020-04539-8","article-title":"Diagnosis and identification of Leishmania species in patients with cutaneous leishmaniasis in the state of Roraima, Brazil\u2019s Amazon Region","volume":"14","author":"Fuzari","year":"2021","journal-title":"Parasites Vectors"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ad.2021.02.008","article-title":"Leishmaniasis cut\u00e1nea y mucocut\u00e1nea","volume":"112","author":"Diago","year":"2021","journal-title":"Actas Dermo-Sifiliogr."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1365-4632.2007.03154.x","article-title":"Clinical manifestations and classification of Old World cutaneous leishmaniasis","volume":"46","author":"Akilov","year":"2007","journal-title":"Int. J. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.clindermatol.2019.10.008","article-title":"Cutaneous leishmaniasis: A great imitator","volume":"38","author":"Gurel","year":"2020","journal-title":"Clin. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Alcover, M.M., Rocamora, V., Ribas, A., Fisa, R., and Riera, C. (2023). Underestimation of Human Cutaneous Leishmaniasis Caused by Leishmania infantum in an Endemic Area of the Mediterranean Basin (Balearic Islands). Microorganisms, 11.","DOI":"10.3390\/microorganisms11010126"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Eichenberger, A., Buechi, A.E., Neumayr, A., Hatz, C., Rauch, A., Huguenot, M., Diamantis-Karamitopoulou, E., and Staehelin, C. (2017). A severe case of visceral leishmaniasis and liposomal amphotericin B treatment failure in an immunosuppressed patient 15 years after exposure. BMC Infect. Dis., 17.","DOI":"10.1186\/s12879-017-2192-4"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.drudis.2019.03.007","article-title":"Walking a tightrope: Drug discovery in visceral leishmaniasis","volume":"24","author":"Reguera","year":"2019","journal-title":"Drug Discov. Today"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1021\/acsinfecdis.0c00864","article-title":"Bioluminescent Imaging Identifies Thymus, As Overlooked Colonized Organ, in a Chronic Model of Leishmania donovani Mouse Visceral Leishmaniasis","volume":"7","author":"Iborra","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Lekic, N., Tadic, B., Djordjevic, V., Basaric, D., Micev, M., Vucelic, D., Mitrovic, M., and Grubor, N. (2022). Splenectomy for Visceral Leishmaniasis Out of an Endemic Region: A Case Report and Literature Review. Medicina, 58.","DOI":"10.3390\/medicina58020184"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Costa, C.H.N., Chang, K.P., Costa, D.L., and Cunha, F.V.M. (2023). From Infection to Death: An Overview of the Pathogenesis of Visceral Leishmaniasis. Pathogens, 12.","DOI":"10.3390\/pathogens12070969"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Volpedo, G., Pachezo-Fernandez, T., Holcomb, E.A., Cipriano, N., Cox, B., and Satoskar, A.R. (2021). Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL). Front. Cell. Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.685296"},{"key":"ref_46","first-page":"CD015374","article-title":"Chemotherapy for second-stage human African trypanosomiasis: Drugs in use","volume":"12","author":"Lutje","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Estrada, C., P\u00e9rez-Pertejo, Y., Dom\u00ednguez-Asenjo, B., Holanda, V.N., Murugesan, S., Mart\u00ednez-Valladares, M., Bala\u00f1a-Fouce, R., and Reguera, R.M. (2023). Further investigations of nitroheterocyclic compounds as potential antikinetoplastid drug candidates. Biomolecules, 13.","DOI":"10.3390\/biom13040637"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1515\/pac-2018-1102","article-title":"Current and promising novel drug candidates against visceral leishmaniasis","volume":"91","author":"Reguera","year":"2019","journal-title":"Pure Appl. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.4269\/ajtmh.17-0736","article-title":"The elderly responds to antimony therapy for cutaneous leishmaniasis similarly to young patients but have severe adverse reactions","volume":"98","author":"Lago","year":"2018","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1080\/14656566.2019.1609940","article-title":"Current and emerging medications for the treatment of leishmaniasis","volume":"20","author":"Chakravarty","year":"2019","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"106459","DOI":"10.1016\/j.ijantimicag.2021.106459","article-title":"An update on the clinical pharmacology of miltefosine in the treatment of leishmaniasis","volume":"59","author":"Beijnen","year":"2022","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ijpddr.2014.05.001","article-title":"Target-based vs. phenotypic screenings in Leishmania drug discovery: A marriage of convenience or a dialogue of the deaf?","volume":"4","author":"Reguera","year":"2014","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1007\/s00436-020-06736-x","article-title":"An overview of biochemically characterized drug targets in metabolic pathways of Leishmania parasite","volume":"119","author":"Raj","year":"2020","journal-title":"Parasitol. Res."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Kourbeli, V., Chontzopoulou, E., Moschovou, K., Pavlos, D., Mavromoustakos, T., and Papanastasiou, I.P. (2021). An overview on target-based drug design against kinetoplastid protozoan infections: Human African trypanosomiasis, Chagas disease and leishmaniases. Molecules, 26.","DOI":"10.3390\/molecules26154629"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Jain, S., Sahu, U., Kumar, A., and Khare, P. (2022). Metabolic pathways of Leishmania parasite: Source of pertinent drug targets and potent drug candidates. Pharmaceutics, 14.","DOI":"10.20944\/preprints202206.0355.v1"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-Pertejo, Y., Garc\u00eda-Estrada, C., Mart\u00ednez-Valladares, M., Murugesan, S., Reguera, R.M., and Bala\u00f1a-Fouce, R. (2024). Polyamine Metabolism for Drug Intervention in Trypanosomatids. Pathogens, 13.","DOI":"10.3390\/pathogens13010079"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/bs.apar.2022.04.002","article-title":"Unique thiol metabolism in trypanosomatids: Redox homeostasis and drug resistance","volume":"117","author":"Ali","year":"2022","journal-title":"Adv. Parasitol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-1-0716-2736-5_2","article-title":"The Trypanosomatids Cell Cycle: A Brief Report","volume":"Volume 2579","author":"Wang","year":"2022","journal-title":"Cell-Cycle Synchronization"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.ijpara.2007.04.003","article-title":"Transmission of Leishmania metacyclic promastigotes by phlebotomine sand flies","volume":"37","author":"Bates","year":"2007","journal-title":"Int. J. Parasitol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1098\/rstb.2008.0151","article-title":"Inflammation and oxidative stress in vertebrate host-parasite systems","volume":"364","author":"Sorci","year":"2009","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Mes\u00edas, A.C., Garg, N.J., and Zago, M.P. (2019). Redox balance keepers and possible cell functions managed by redox homeostasis in Trypanosoma cruzi. Front. Cell. Infect. Microbiol., 9.","DOI":"10.3389\/fcimb.2019.00435"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1113\/jphysiol.2003.049478","article-title":"Mitochondrial formation of reactive oxygen species","volume":"552","author":"Turrens","year":"2003","journal-title":"J. Physiol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Zabala-Pe\u00f1afiel, A., Cysne-Finkelstein, L., Concei\u00e7\u00e3o-Silva, F., Fagundes, A., Miranda, L.F.C., Souza-Silva, F., Brandt, A.A.M.L., Dias-Lopes, G., and Alves, C.R. (2022). Novel Insights Into Leishmania (Viannia) braziliensis In Vitro Fitness Guided by Temperature Changes Along with Its Subtilisins and Oligopeptidase. Front. Cell. Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.805106"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.bbamcr.2016.11.001","article-title":"Consequences of acute oxidative stress in Leishmania amazonensis: From telomere shortening to the selection of the fittest parasites","volume":"1864","author":"Segatto","year":"2017","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Cell Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.bbagen.2008.03.006","article-title":"Redox control in trypanosomatids, parasitic protozoa with trypanothione-based thiol metabolism","volume":"1780","author":"Comini","year":"2008","journal-title":"Biochim. Biophys. Acta (BBA)-Gen. Subj."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.mam.2004.02.021","article-title":"Oxidative stress and antioxidant defenses: A target for the treatment of diseases caused by parasitic protozoa","volume":"25","author":"Turrens","year":"2004","journal-title":"Mol. Asp. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0891-5849(99)00172-0","article-title":"Glutathione and trypanothione in parasitic hydroperoxide metabolism","volume":"27","author":"Hecht","year":"1999","journal-title":"Free Radic. Biol. Med."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Castro, H., Romao, S., Carvalho, S., Teixeira, F., Sousa, C., and Tomas, A.M. (2010). Mitochondrial Redox Metabolism in Trypanosomatids Is Independent of Tryparedoxin Activity. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0012607"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1126\/science.3883489","article-title":"Trypanothione: A novel bis(glutathionyl)spermidine cofactor for glutathione reductase in trypanosomatids","volume":"227","author":"Fairlamb","year":"1985","journal-title":"Science"},{"key":"ref_70","first-page":"539","article-title":"The parasite-specific trypanothione metabolism of Trypanosoma and Leishmania","volume":"384","author":"Meiering","year":"2003","journal-title":"Biol. Chem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1016\/j.bbagen.2013.01.013","article-title":"Trypanothione: A unique bis-glutathionyl derivative in trypanosomatids","volume":"1830","author":"Manta","year":"2013","journal-title":"Biochim. Biophys. Acta (BBA)-Gen. Subj."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"6809","DOI":"10.1074\/jbc.M210392200","article-title":"A second class of peroxidases linked to the trypanothione metabolism","volume":"278","author":"Hillebrand","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1046\/j.1365-2958.2000.01721.x","article-title":"Trypanosomes lacking trypanothione reductase are avirulent and show increased sensitivity to oxidative stress","volume":"35","author":"Krieger","year":"2000","journal-title":"Mol. Microbiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"444","DOI":"10.5483\/BMBRep.2008.41.6.444","article-title":"Modeled structure of trypanothione reductase of Leishmania infantum","volume":"41","author":"Singh","year":"2008","journal-title":"BMB Rep."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1089\/ars.2008.2050","article-title":"Peroxidases of trypanosomatids","volume":"10","author":"Castro","year":"2008","journal-title":"Antioxid. Redox Signal."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.4155\/fmc.13.146","article-title":"Structural insights into the enzymes of the trypanothione pathway: Targets for antileishmaniasis drugs","volume":"5","author":"Colotti","year":"2013","journal-title":"Future Med. Chem."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"35853","DOI":"10.1074\/jbc.M204403200","article-title":"A single enzyme catalyses formation of Trypanothione from glutathione and spermidine in Trypanosoma cruzi","volume":"277","author":"Oza","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"18746","DOI":"10.1074\/jbc.TM118.003342","article-title":"Polyamines in protozoan pathogens","volume":"293","author":"Phillips","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cca.2005.02.006","article-title":"Polyamine transport in parasites: A potential target for new antiparasitic drug development","volume":"140","author":"Reguera","year":"2005","journal-title":"Comp. Biochem. Physiol. Part C Toxicol. Pharmacol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.molbiopara.2011.10.007","article-title":"Role of trypanosomatid\u2019s arginase in polyamine biosynthesis and pathogenesis","volume":"181","author":"Prada","year":"2012","journal-title":"Mol. Biochem. Parasitol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molbiopara.2006.11.013","article-title":"S-Adenosylmethionine in protozoan parasites: Functions, synthesis and regulation","volume":"152","author":"Reguera","year":"2007","journal-title":"Mol. Biochem. Parasitol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.biotechadv.2011.05.012","article-title":"The trypanothione system and the opportunities it offers to create drugs for the neglected kinetoplast diseases","volume":"30","year":"2012","journal-title":"Biotechnol. Adv."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.freeradbiomed.2014.05.007","article-title":"Genetic and chemical analyses reveal that trypanothione synthetase but not glutathionylspermidine synthetase is essential for Leishmania infantum","volume":"73","author":"Sousa","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2958.2009.06761.x","article-title":"Dissecting the essentiality of the bifunctional trypanothione synthetase-amidase in Trypanosoma brucei using chemical and genetic methods","volume":"74","author":"Wyllie","year":"2009","journal-title":"Mol. Microbiol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.freeradbiomed.2018.10.436","article-title":"Trypanothione synthetase confers growth, survival advantage and resistance to anti-protozoal drugs in Trypanosoma cruzi","volume":"130","author":"Sasoni","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"17672","DOI":"10.1074\/jbc.M801850200","article-title":"Leishmania trypanothione synthetase-amidase structure reveals a basis for regulation of conflicting synthetic and hydrolytic activities","volume":"283","author":"Fyfe","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1042\/bj20011370","article-title":"Characterization of recombinant glutathionylspermidine synthetase\/amidase from Crithidia fasciculata","volume":"364","author":"Oza","year":"2002","journal-title":"Biochem. J."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0969-2126(99)80011-2","article-title":"Crystal structure of Trypanosoma cruzi trypanothione reductase in complex with trypanothione, and the structure-based discovery of new natural product inhibitors","volume":"7","author":"Bond","year":"1999","journal-title":"Structure"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/cmdc.201300176","article-title":"Inhibition of Leishmania infantum trypanothione reductase by azole-based compounds: A comparative analysis with its physiological substrate by X-ray crystallography","volume":"8","author":"Baiocco","year":"2013","journal-title":"ChemMedChem"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.molbiopara.2009.09.002","article-title":"Comparative structural, kinetic and inhibitor studies of Trypanosoma brucei trypanothione reductase with T. cruzi","volume":"169","author":"Jones","year":"2010","journal-title":"Mol. Biochem. Parasitol."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Battista, T., Colotti, G., Ilari, A., and Fiorillo, A. (2020). Targeting Trypanothione Reductase, a Key Enzyme in the Redox Trypanosomatid Metabolism, to Develop New Drugs against Leishmaniasis and Trypanosomiases. Molecules, 25.","DOI":"10.3390\/molecules25081924"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.2174\/1381612826666201211115329","article-title":"Trypanothione Metabolism as Drug Target for Trypanosomatids","volume":"27","author":"Arias","year":"2021","journal-title":"Curr. Pharm. Des."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s10930-022-10052-x","article-title":"Probing the Interactions Responsible for the Structural Stability of Trypanothione Reductase Through Computer Simulation and Biophysical Characterization","volume":"41","author":"Kumar","year":"2022","journal-title":"Protein J."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Madia, V.N., Ialongo, D., Patacchini, E., Exertier, C., Antonelli, L., Colotti, G., Messore, A., Tudino, V., Saccoliti, F., and Scipione, L. (2023). Inhibition of Leishmania infantum Trypanothione Reductase by New Aminopropanone Derivatives Interacting with the NADPH Binding Site. Molecules, 28.","DOI":"10.3390\/molecules28010338"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1002\/cmdc.202000325","article-title":"Recent Advancement in the Search of Innovative Antiprotozoal Agents Targeting Trypanothione Metabolism","volume":"15","author":"Saccoliti","year":"2020","journal-title":"ChemMedChem"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/(SICI)1097-0134(199601)24:1<73::AID-PROT5>3.0.CO;2-P","article-title":"Crystal structure of the Trypanosoma cruzi trypanothione reductase mepacrine complex","volume":"24","author":"Jacoby","year":"1996","journal-title":"Proteins"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"5448","DOI":"10.1021\/jm990386s","article-title":"Inhibition of Trypanosoma cruzi trypanothione reductase by acridines: Kinetic studies and structure-activity relationships","volume":"42","author":"Bonse","year":"1999","journal-title":"J. Med. Chem."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"29493","DOI":"10.1074\/jbc.M403187200","article-title":"Two interacting binding sites for quinacrine derivatives in the active site of trypanothione reductase: A template for drug design","volume":"279","author":"Saravanamuthu","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.compbiolchem.2016.10.002","article-title":"Identification of potential inhibitor and enzyme-inhibitor complex on trypanothione reductase to control Chagas disease","volume":"65","author":"Hossain","year":"2016","journal-title":"Comput. Biol. Chem."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1016\/S0960-894X(01)00528-5","article-title":"Antiprotozoal and cytotoxicity evaluation of sulfonamide and urea analogues of quinacrine","volume":"11","author":"Chibale","year":"2001","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1002\/cmdc.200900327","article-title":"Synthesis, inhibition potency, binding mode, and antiprotozoal activities of fluorescent inhibitors of trypanothione reductase based on mepacrine-conjugated diaryl sulfide scaffolds","volume":"4","author":"Eberle","year":"2009","journal-title":"ChemMedChem"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/cmdc.200900097","article-title":"Improved tricyclic inhibitors of trypanothione reductase by screening and chemical synthesis","volume":"4","author":"Richardson","year":"2009","journal-title":"ChemMedChem"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/cmdc.200900098","article-title":"Synthesis and evaluation of 1-(1-(Benzo[b]thiophen-2-yl)cyclohexyl)piperidine (BTCP) analogues as inhibitors of trypanothione reductase","volume":"4","author":"Patterson","year":"2009","journal-title":"ChemMedChem"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/cmdc.201000420","article-title":"Improved inhibitors of trypanothione reductase by combination of motifs: Synthesis, inhibitory potency, binding mode, and antiprotozoal activities","volume":"6","author":"Eberle","year":"2011","journal-title":"ChemMedChem"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/cmdc.201800067","article-title":"Biological Evaluation and X-ray Co-crystal Structures of Cyclohexylpyrrolidine Ligands for Trypanothione Reductase, an Enzyme from the Redox Metabolism of Trypanosoma","volume":"13","author":"Bryson","year":"2018","journal-title":"ChemMedChem"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"11416","DOI":"10.1002\/chem.201901664","article-title":"Targeting a Large Active Site: Structure-Based Design of Nanomolar Inhibitors of Trypanosoma brucei Trypanothione Reductase","volume":"25","author":"Halgas","year":"2019","journal-title":"Chemistry"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1128\/AAC.01568-08","article-title":"Trypanothione reductase high-throughput screening campaign identifies novel classes of inhibitors with antiparasitic activity","volume":"53","author":"Holloway","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"6514","DOI":"10.1021\/jm200312v","article-title":"Dihydroquinazolines as a novel class of Trypanosoma brucei trypanothione reductase inhibitors: Discovery, synthesis, and characterization of their binding mode by protein crystallography","volume":"54","author":"Patterson","year":"2011","journal-title":"J. Med. Chem."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Matadamas-Mart\u00ednez, F., Hern\u00e1ndez-Campos, A., T\u00e9llez-Valencia, A., V\u00e1zquez-Raygoza, A., Compar\u00e1n-Alarc\u00f3n, S., Y\u00e9pez-Mulia, L., and Castillo, R. (2019). Leishmania mexicana Trypanothione Reductase Inhibitors: Computational and Biological Studies. Molecules, 24.","DOI":"10.3390\/molecules24183216"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Turcano, L., Battista, T., De Haro, E.T., Missineo, A., Alli, C., Paonessa, G., Colotti, G., Harper, S., Fiorillo, A., and Ilari, A. (2020). Spiro-containing derivatives show antiparasitic activity against Trypanosoma brucei through inhibition of the trypanothione reductase enzyme. PLoS Negl. Trop. Dis., 14.","DOI":"10.1371\/journal.pntd.0008339"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1080\/14756366.2016.1250755","article-title":"Inhibition of Leishmania infantum trypanothione reductase by diaryl sulfide derivatives","volume":"32","author":"Saccoliti","year":"2017","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00726-019-02731-4","article-title":"Structure-guided approach to identify a novel class of anti-leishmaniasis diaryl sulfide compounds targeting the trypanothione metabolism","volume":"52","author":"Colotti","year":"2020","journal-title":"Amino Acids"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"e00524-20","DOI":"10.1128\/AAC.00524-20","article-title":"New Amides Containing Selenium as Potent Leishmanicidal Agents Targeting Trypanothione Reductase","volume":"65","author":"Plano","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.saa.2010.12.017","article-title":"ESR, electrochemical, molecular modeling and biological evaluation of 4-substituted and 1,4-disubstituted 7-nitroquinoxalin-2-ones as potential anti-Trypanosoma cruzi agents","volume":"78","author":"Norambuena","year":"2011","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1021\/acsinfecdis.2c00325","article-title":"Optimization of Potent and Specific Trypanothione Reductase Inhibitors: A Structure-Based Drug Discovery Approach","volume":"8","author":"Battista","year":"2022","journal-title":"ACS Infect. Dis."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1021\/acs.jmedchem.3c01439","article-title":"Fragment Merging, Growing, and Linking Identify New Trypanothione Reductase Inhibitors for Leishmaniasis","volume":"67","author":"Exertier","year":"2024","journal-title":"J. Med. Chem."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1432-1033.1995.tb20583.x","article-title":"Trypanothione reductase from Leishmania donovani. Purification, characterisation and inhibition by trivalent antimonials","volume":"230","author":"Cunningham","year":"1995","journal-title":"Eur. J. Biochem."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1021\/jm900185q","article-title":"Molecular basis of antimony treatment in leishmaniasis","volume":"52","author":"Baiocco","year":"2009","journal-title":"J. Med. Chem."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1021\/ml1002629","article-title":"Inhibitory Effect of Silver Nanoparticles on Trypanothione Reductase Activity and Leishmania infantum Proliferation","volume":"2","author":"Baiocco","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/cmdc.201300276","article-title":"Metal-based compounds as prospective antileishmanial agents: Inhibition of trypanothione reductase by selected gold complexes","volume":"8","author":"Colotti","year":"2013","journal-title":"ChemMedChem"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00726-011-0997-9","article-title":"A gold-containing drug against parasitic polyamine metabolism: The X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition","volume":"42","author":"Ilari","year":"2012","journal-title":"Amino Acids"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1021\/jm000219o","article-title":"(2,2\u2019:6\u2019,2\u2019\u2019-Terpyridine)platinum(II) complexes are irreversible inhibitors of Trypanosoma cruzi trypanothione reductase but not of human glutathione reductase","volume":"43","author":"Bonse","year":"2000","journal-title":"J. Med. Chem."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1021\/jm0512241","article-title":"Novel antitrypanosomal agents based on palladium nitrofurylthiosemicarbazone complexes: DNA and redox metabolism as potential therapeutic targets","volume":"49","author":"Otero","year":"2006","journal-title":"J. Med. Chem."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Turcano, L., Torrente, E., Missineo, A., Andreini, M., Gramiccia, M., Di Muccio, T., Genovese, I., Fiorillo, A., Harper, S., and Bresciani, A. (2018). Identification and binding mode of a novel Leishmania Trypanothione reductase inhibitor from high throughput screening. PLoS Negl. Trop. Dis., 12.","DOI":"10.1371\/journal.pntd.0006969"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/cbic.201200744","article-title":"Probing the dimerization interface of Leishmania infantum trypanothione reductase with site-directed mutagenesis and short peptides","volume":"14","author":"Toro","year":"2013","journal-title":"Chembiochem"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1111\/bph.15250","article-title":"Pseudoirreversible slow-binding inhibition of trypanothione reductase by a protein-protein interaction disruptor","volume":"177","author":"Toro","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1021\/acsinfecdis.8b00355","article-title":"Pyrrolopyrimidine vs. Imidazole-Phenyl-Thiazole Scaff olds in Nonpeptidic Dimerization Inhibitors of Leishmania infantum Trypanothione Reductase","volume":"5","author":"Revuelto","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"6137","DOI":"10.1021\/acs.jmedchem.1c00206","article-title":"Efficient Dimerization Disruption of Leishmania infantum Trypanothione Reductase by Triazole-phenyl-thiazoles","volume":"64","author":"Revuelto","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejmech.2017.10.005","article-title":"Crassiflorone derivatives that inhibit Trypanosoma brucei glyceraldehyde-3-phosphate dehydrogenase (TbGAPDH) and Trypanosoma cruzi trypanothione reductase (TcTR) and display trypanocidal activity","volume":"141","author":"Uliassi","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-Gonz\u00e1lez, A., S\u00e1nchez-S\u00e1nchez, O., Krauth-Siegel, R.L., Bolognesi, M.L., G\u1edbmez-Escobedo, R., Nogueda-Torres, B., V\u00e1zquez-Jim\u00e9nez, L.K., Saavedra, E., Encalada, R., and Espinoza-Hicks, J.C. (2022). In Vitro and In Silico Analysis of New n-Butyl and Isobutyl Quinoxaline-7-carboxylate 1,4-di-N-oxide Derivatives against Trypanosoma cruzi as Trypanothione Reductase Inhibitors. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232113315"},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Espinosa-Bustos, C., Ortiz-P\u00e9rez, M., Gonz\u00e1lez-Gonz\u00e1lez, A., Zarate, A.M., Rivera, G., Belmont-D\u00edaz, J.A., Saavedra, E., Cuellar, M.A., V\u00e1zquez, K., and Salas, C.O. (2022). New Amino Naphthoquinone Derivatives as Anti-Trypanosoma cruzi Agents Targeting Trypanothione Reductase. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14061121"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"113915","DOI":"10.1016\/j.ejmech.2021.113915","article-title":"Pyridazino-pyrrolo-quinoxalinium salts as highly potent and selective leishmanicidal agents targeting trypanothione reductase","volume":"227","author":"Toro","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"e2300069","DOI":"10.1002\/minf.202300069","article-title":"Phenothiazine-based virtual screening, molecular docking, and molecular dynamics of new trypanothione reductase inhibitors of Trypanosoma cruzi","volume":"42","author":"Encalada","year":"2023","journal-title":"Mol. Inform."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.1073\/pnas.85.15.5374","article-title":"\u201cSubversive\u201d substrates for the enzyme trypanothione disulfide reductase: Alternative approach to chemotherapy of Chagas disease","volume":"85","author":"Henderson","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1039\/b802649c","article-title":"The aza-analogues of 1,4-naphthoquinones are potent substrates and inhibitors of plasmodial thioredoxin and glutathione reductases and of human erythrocyte glutathione reductase","volume":"6","author":"Morin","year":"2008","journal-title":"Org. Biomol. Chem."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1021\/jm001079l","article-title":"2- and 3-substituted 1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: Synthesis and correlation between redox cycling activities and in vitro cytotoxicity","volume":"44","author":"Buisine","year":"2001","journal-title":"J. Med. Chem."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1006\/bbrc.1994.2448","article-title":"Chinifur, a selective inhibitor and \u201csubversive substrate\u201d for Trypanosoma congolense trypanothione reductase","volume":"204","author":"Cenas","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0006-2952(99)00264-6","article-title":"Nitrofuran drugs as common subversive substrates of Trypanosoma cruzi lipoamide dehydrogenase and trypanothione reductase","volume":"58","author":"Blumenstiel","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.ejmech.2016.10.055","article-title":"Rational design of nitrofuran derivatives: Synthesis and valuation as inhibitors of Trypanosoma cruzi trypanothione reductase","volume":"125","author":"Arias","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1021\/acsinfecdis.1c00139","article-title":"Ex Vivo Phenotypic Screening of Two Small Repurposing Drug Collections Identifies Nifuratel as a Potential New Treatment against Visceral and Cutaneous Leishmaniasis","volume":"7","author":"Reguera","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Melc\u00f3n-Fernandez, E., Galli, G., Garc\u00eda-Estrada, C., Bala\u00f1a-Fouce, R., Reguera, R.M., and P\u00e9rez-Pertejo, Y. (2023). Miltefosine and Nifuratel Combination: A Promising Therapy for the Treatment of Leishmania donovani Visceral Leishmaniasis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24021635"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s11030-021-10265-9","article-title":"Ensemble learning application to discover new trypanothione synthetase inhibitors","volume":"25","author":"Alice","year":"2021","journal-title":"Mol. Divers."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.molbiopara.2015.11.003","article-title":"Thiol redox biology of trypanosomatids and potential targets for chemotherapy","volume":"206","author":"Leroux","year":"2016","journal-title":"Mol. Biochem. Parasitol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/9783527670383.ch23","article-title":"Inhibition of trypanothione synthetase as a therapeutic concept","volume":"Volume 4","author":"Koch","year":"2013","journal-title":"Trypanosomatid Diseases: Molecular Routes to Drug Discovery"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ejmech.2014.06.020","article-title":"9- and 11-Substituted 4-azapaullones are potent and selective inhibitors of African trypanosoma","volume":"83","author":"Maiwald","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Ben\u00edtez, D., Medeiros, A., Fiestas, L., Panozzo-Zenere, E.A., Maiwald, F., Prousis, K.C., Roussaki, M., Calogeropoulou, T., Detsi, A., and Jaeger, T. (2016). Identification of Novel Chemical Scaffolds Inhibiting Trypanothione Synthetase from Pathogenic Trypanosomatids. PLoS Negl. Trop. Dis., 10.","DOI":"10.1371\/journal.pntd.0004617"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1016\/j.bmc.2016.06.023","article-title":"5-Substituted 3-chlorokenpaullone derivatives are potent inhibitors of Trypanosoma brucei bloodstream forms","volume":"24","author":"Orban","year":"2016","journal-title":"Bioorganic Med. Chem."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1080\/14756366.2020.1780227","article-title":"Mechanistic and biological characterisation of novel N5-substituted paullones targeting the biosynthesis of trypanothione in Leishmania","volume":"35","author":"Medeiros","year":"2020","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Ihnatenko, I., M\u00fcller, M.J., Orban, O.C.F., Lindhof, J.C., Ben\u00edtez, D., Ort\u00edz, C., Dibello, E., Seidl, L.L., Comini, M.A., and Kunick, C. (2023). The indole motif is essential for the antitrypanosomal activity of N5-substituted paullones. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0292946"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1515\/BC.2011.222","article-title":"Cloning, expression, characterization and inhibition studies on trypanothione synthetase, a drug target enzyme, from Leishmania donovani","volume":"392","author":"Saudagar","year":"2011","journal-title":"Biol. Chem."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"7202","DOI":"10.1016\/j.bmc.2013.08.052","article-title":"Cynaropicrin targets the trypanothione redox system in Trypanosoma brucei","volume":"21","author":"Zimmermann","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"36137","DOI":"10.1074\/jbc.M109.045336","article-title":"Chemical validation of trypanothione synthetase: A potential drug target for human trypanosomiasis","volume":"284","author":"Torrie","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/cmdc.201100420","article-title":"Design, synthesis and biological evaluation of Trypanosoma brucei trypanothione synthetase inhibitors","volume":"7","author":"Spinks","year":"2012","journal-title":"ChemMedChem"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ejpb.2013.08.014","article-title":"Molecular mechanism underlying antileishmanial effect of oxabicyclo [3.3.1]nonanones: Inhibition of key redox enzymes of the pathogen","volume":"85","author":"Saudagar","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"13704","DOI":"10.1016\/S0021-9258(18)33504-X","article-title":"Mechanism of action, metabolism, and toxicity of buthionine sulfoximine and its higher homologs, potent inhibitors of glutathione synthesis","volume":"257","author":"Griffith","year":"1982","journal-title":"J. Biol. Chem."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1002\/1873-3468.12904","article-title":"Buthionine sulfoximine is a multitarget inhibitor of trypanothione synthesis in Trypanosoma cruzi","volume":"591","author":"Silva","year":"2017","journal-title":"FEBS Lett."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1080\/14756366.2022.2045590","article-title":"Drug-like molecules with anti-trypanothione synthetase activity identified by high throughput screening","volume":"37","author":"Franco","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"114675","DOI":"10.1016\/j.ejmech.2022.114675","article-title":"Identification of L. infantum trypanothione synthetase inhibitors with leishmanicidal activity from a (non-biased) in-house chemical library","volume":"243","author":"Revuelto","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.bbrc.2022.11.044","article-title":"Discovery of novel Leishmania major trypanothione synthetase inhibitors by high-throughput screening","volume":"637","author":"Phan","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/29\/10\/2214\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:42:33Z","timestamp":1760107353000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/29\/10\/2214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,9]]},"references-count":159,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["molecules29102214"],"URL":"https:\/\/doi.org\/10.3390\/molecules29102214","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,9]]}}}